We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

69 hedge funds and large institutions have $614M invested in Dyne Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 13

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

38% more funds holding

Funds holding: 50 → 69 (+19)

12% more capital invested

Capital invested by funds: $550M → $614M (+$64.9M)

3.95% more ownership

Funds ownership: 60.52% → 64.47% (+4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
69
Holders Change
+19
Holders Change %
+38%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
32
Increased
13
Reduced
9
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$14.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$12.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.16M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.67M
5
WP
Woodline Partners
California
+$4.43M

Top Sellers

1
SAM
Sectoral Asset Management
Quebec, Canada
-$9.58M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.04M
3
Franklin Resources
Franklin Resources
California
-$4.85M
4
FCM
Farallon Capital Management
California
-$4.04M
5
Millennium Management
Millennium Management
New York
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
MPM Asset Management
Massachusetts
$104M – – –
Citadel Advisors
2
Citadel Advisors
Florida
$66.5M +$3.88M +195,927 +7%
VVA
3
Vida Ventures Advisors
Massachusetts
$62.2M – – –
Wellington Management Group
4
Wellington Management Group
Massachusetts
$60.3M +$7.16M +361,962 +14%
RCM
5
RA Capital Management
Massachusetts
$58.9M – – –
LGM
6
Logos Global Management
California
$33.7M – – –
Franklin Resources
7
Franklin Resources
California
$31.5M -$4.85M -245,352 -14%
BlackRock
8
BlackRock
New York
$21.8M +$14.5M +732,117 +241%
Vanguard Group
9
Vanguard Group
Pennsylvania
$14.5M +$12.8M +645,582 +1,435%
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
$13.2M -$7.04M -356,111 -36%
HA
11
HHLR Advisors
Cayman Islands
$12.6M – – –
DM
12
Deerfield Management
New York
$12M +$3.14M +158,733 +39%
WP
13
Woodline Partners
California
$10.3M +$4.43M +224,187 +84%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$10.2M -$129K -6,519 -1%
OCA
15
Octagon Capital Advisors
New York
$10.1M +$9.52M +481,538 New
Norges Bank
16
Norges Bank
Norway
$8.4M -$1.6M -80,769 -17%
PA
17
Perceptive Advisors
New York
$8.4M – – –
CC
18
Casdin Capital
New York
$7.77M – – –
O
19
OrbiMed
New York
$7.35M – – –
VC
20
Vivo Capital
California
$6.62M – – –
AG
21
Artal Group
Luxembourg
$6.3M -$1.38M -70,000 -19%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$4.96M +$4.67M +236,005 New
State Street
23
State Street
Massachusetts
$4.66M +$4.39M +222,004 New
EC
24
EcoR1 Capital
California
$4.51M – – –
CCM
25
CAAS Capital Management
New York
$3.9M +$3.46M +174,911 +1,590%
1
2 3 4

DYN Hedge Fund Activity: Q4 2020 in Review

69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2020, worth a combined $614M — up 12% from $550M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new DYN positions and 13 closed out — a net gain of 19 holders — while 13 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $9.58M sold.

  • 69 institutional investors held Dyne Therapeutics (DYN) as of Q4 2020, up from 50 in Q3 2020.
  • Funds reported $614M of Dyne Therapeutics stock for Q4 2020, up 12% quarter-over-quarter.
  • 32 funds opened new Dyne Therapeutics positions in Q4 2020 and 13 closed out, a net change of +19 holders.
  • The largest Dyne Therapeutics buyer in Q4 2020 was BlackRock, an estimated $14.5M added.
  • The largest Dyne Therapeutics seller in Q4 2020 was Sectoral Asset Management, an estimated $9.58M sold.

Based on aggregated 13F filings for Q4 2020.